N.n. Alexandrov National Cancer Centre

This clinical trial is testing a new treatment approach for people with cervical cancer that has spread, come back, or not gone away after standard treatment. The study combines immunotherapy drugs (PD-1/PD-L1 inhibitors) with chemotherapy, with or without another targeted drug (…

This study tests whether a combination of two drugs (a PARP inhibitor and an angiogenesis inhibitor) can help keep advanced ovarian, fallopian-tube, or primary peritoneal cancer from coming back after initial treatment. About 120 adults with a specific genetic feature (HRD) will …

This study is testing a lower-cost, lab-made version of CAR-T cell therapy for adults with relapsed or refractory large B-cell lymphoma. The treatment uses a patient's own immune cells, modified to target and kill cancer cells. The goal is to see if this academic approach is safe…

This study looks at men with prostate cancer who are having surgery to remove their prostate. It compares removing few or no lymph nodes versus removing many lymph nodes during the same operation. The goal is to see which approach helps prevent cancer from spreading to other part…